Calyxt (CLXT) Posts Earnings Results, Misses Estimates By $0.01 EPS

Calyxt (NASDAQ:CLXT) posted its quarterly earnings results on Monday. The company reported ($0.26) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.25) by ($0.01), Fidelity Earnings reports. Calyxt had a negative net margin of 6,256.67% and a negative return on equity of 33.08%.

Calyxt stock traded down $0.81 during mid-day trading on Tuesday, hitting $16.88. 3,284 shares of the company’s stock were exchanged, compared to its average volume of 53,869. The company has a market capitalization of $576.20 million, a PE ratio of -15.10 and a beta of 2.70. Calyxt has a fifty-two week low of $8.83 and a fifty-two week high of $22.32. The company has a current ratio of 15.01, a quick ratio of 15.01 and a debt-to-equity ratio of 0.17.

Several brokerages recently commented on CLXT. National Securities began coverage on Calyxt in a research note on Wednesday, March 6th. They set a “buy” rating and a $35.00 price objective on the stock. Citigroup raised their price objective on Calyxt from $13.00 to $16.00 and gave the stock a “neutral” rating in a research note on Wednesday, February 27th. Zacks Investment Research raised Calyxt from a “sell” rating to a “hold” rating in a research note on Thursday, February 21st. Finally, Goldman Sachs Group raised Calyxt from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $9.25 to $18.00 in a research note on Sunday, December 16th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $21.80.



In other Calyxt news, insider Manoj Sahoo sold 2,444 shares of Calyxt stock in a transaction dated Wednesday, January 2nd. The stock was sold at an average price of $10.39, for a total value of $25,393.16. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Daniel F. Voytas sold 8,170 shares of Calyxt stock in a transaction dated Friday, February 1st. The shares were sold at an average price of $13.00, for a total value of $106,210.00. The disclosure for this sale can be found here. Insiders have sold a total of 19,791 shares of company stock worth $261,718 in the last ninety days. 2.80% of the stock is currently owned by company insiders.

WARNING: “Calyxt (CLXT) Posts Earnings Results, Misses Estimates By $0.01 EPS” was posted by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this report can be accessed at https://dakotafinancialnews.com/2019/03/12/calyxt-clxt-posts-earnings-results-misses-estimates-by-0-01-eps.html.

About Calyxt

Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.

Further Reading: How Buying a Call Option Works

Earnings History for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.